One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Search from 250 M+ research papersSearch from 250 M+ research papers
Open Accesshttps://doi.org/10.1182/blood-2021-149115
Copy DOI Journal: Blood |  Publication Date: Nov 5, 2021 |
Affiliation: The Ohio State University, Mayo Clinic, Memorial Sloan Kettering Cancer Center, University of California, San Francisco, University of Cincinnati, Leukemia and Lymphoma Society, Emory University, Oregon Health & Science University, University of Florida, The University of Texas Southwestern Medical Center, UPMC Hillman Cancer Center, University of California, Los Angeles, University of Utah, Huntsman Cancer Institute, University of Maryland, Baltimore, University of Kansas, University of Chicago, University of North Carolina at Chapel Hill, State Library of OhioIvosidenib (IVO) in Combination with Azacitidine (AZA) in Newly Diagnosed (ND) Older Patients with IDH1 R132-Mutated Acute Myeloid Leukemia (AML) Induces High Response Rates: A Phase 2 Sub-Study of the Beat AML Master Trial
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
